Study of the Clinical Effectiveness of a Human Monoclonal Antibody to C. Difficile Toxin A and Toxin B in Patients With Clostridium Difficile Associated Disease

Mount Sinai Hospital, New York

Christiana Care Health Systems, Newark

All-Trials Clinical Research, LLC, Winston-Salem

Dr. Kiran C. Patel Research Institute, Tampa

University of Kentucky Medical Center, Lexington

Remington-Davis Clinical Research, Columbus

Summa Health System, Akron

Central Indiana Gastroenterology Group, Anderson

Henry Ford Health System, West Bloomfield

Chest, Infectious Diseases and Critical Care Assoc., PC, Des Moines

Mayo Clinic, Rochester

Rapid City Regional Hospital, Rapid City

Saint James Healthcare, Butte

Saint Luke's Hospital of Kansas City, Kansas City

Scott and White Memorial Hospital, Temple

St. Lukes Episcopal Hospital, Houston

Idaho Falls Infectious Diseases, PLLC, Idaho Falls

LAC/USC Medical Center, Los Angeles

UCLA CURE Digestive Diseases Center, Los Angeles

Kaiser Permanente Vaccine Study Center, Oakland

MultiCare Health System Research Services, Tacoma

Jersey Shore University Medical Center, Neptune City

University of Calgary Foothills Medical Center, Calgary

Vancouver Island Health Research Centre, Victoria

Health Sciences Centre, University of Manitoba, Winnepeg

Kingston General Hospital, Kingston

Windsor Regional Hospital, Windsor

Centre de Sante et Services Sociaux de Chicoutimi, Chicoutimi

Centre Hospitalier Regional de Trois-Rivieres, Trois-Rivières